143 related articles for article (PubMed ID: 33552590)
1.
Yang Y; Wang J; Xu S; Lv W; Shi F; Shan A
Transl Neurosci; 2021 Jan; 12(1):9-19. PubMed ID: 33552590
[TBL] [Abstract][Full Text] [Related]
2. BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma.
Yang Y; Wang J; Shi F; Shan A; Xu S; Lv W
Aging (Albany NY); 2021 Mar; 13(5):7499-7516. PubMed ID: 33686021
[TBL] [Abstract][Full Text] [Related]
3. Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma.
Yang Y; Wang J; Xu S; Shi F; Shan A
Transl Neurosci; 2021 Jan; 12(1):67-75. PubMed ID: 33623713
[TBL] [Abstract][Full Text] [Related]
4. IKBIP might be a potential prognostic biomarker for glioblastoma multiforme.
Chen H; Liang B; Luo X; Zhang W; Song X; Lan H; Yue Q; Xie J; Zhang M
Int Immunopharmacol; 2023 May; 118():110030. PubMed ID: 36989893
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characterization and Prognostic Value of TPM4 and Its Correlation with Epithelial-Mesenchymal Transition in Glioma.
Wang J; Yang Y; Du B
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138856
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Clinical Characterization of LIGHT/TNFSF14 Expression at Transcriptional Level
Yang Y; Lv W; Xu S; Shi F; Shan A; Wang J
Front Mol Biosci; 2021; 8():567327. PubMed ID: 34513918
[TBL] [Abstract][Full Text] [Related]
7. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
Li K; Huang G; Wang Z; Yang R; Zhang W; Ni B; Guan J; Yi G; Li Z; Zhu Q; Peng Q; Yang L; Qi L; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166571. PubMed ID: 36244542
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of IKBIP in papillary renal cell carcinoma.
Zhang H; Tang R; Wen X; Cai J; Huang J; Luo L; Yang Z
BMC Urol; 2023 Jul; 23(1):121. PubMed ID: 37454079
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma.
Wang Z; Zhang C; Liu X; Wang Z; Sun L; Li G; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Oncoimmunology; 2016; 5(11):e1196310. PubMed ID: 27999734
[No Abstract] [Full Text] [Related]
10. I kappa B kinase interacting protein as a promising biomarker in pan-cancer: A multi-omics analysis.
Bi C; Wang Z; Xiao Y; Zhao Y; Guo R; Xiong L; Ji Z; Li Y; Li Q; Qin C
Front Genet; 2023; 14():1138137. PubMed ID: 36999060
[No Abstract] [Full Text] [Related]
11. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
12. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract][Full Text] [Related]
13. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
[TBL] [Abstract][Full Text] [Related]
14. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
15. IKBIP is a Predictive Biomarker Related to Immunosuppressive Microenvironment in Digestive System Malignancies.
Li Q; Zhao Z; Pei F; Kang C; Duan F
Discov Med; 2023 Feb; 35(174):57-72. PubMed ID: 37024442
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome profile and clinical characterization of ICOS expression in gliomas.
Wang J; Shi F; Shan A
Front Oncol; 2022; 12():946967. PubMed ID: 36276141
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Liu S; Zhang C; Maimela NR; Yang L; Zhang Z; Ping Y; Huang L; Zhang Y
Oncoimmunology; 2019; 8(7):1601478. PubMed ID: 31143523
[TBL] [Abstract][Full Text] [Related]
18. NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
Sun H; Long S; Wu B; Liu J; Li G
PeerJ; 2020; 8():e8787. PubMed ID: 32211242
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value and Biological Function of Galectins in Malignant Glioma.
Zhu H; Liu D; Cheng L; Liu J; Wang G; Li H; Zhang Y; Mi H; Zhang S; Shu K; Yu X
Front Oncol; 2022; 12():834307. PubMed ID: 35814469
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients.
Liu C; Zhang Z; Ping Y; Qin G; Zhang K; Maimela NR; Huang L; Yang S; Zhang Y
Cancer Manag Res; 2020; 12():4399-4410. PubMed ID: 32606935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
